Motilal Oswal BSE Healthcare ETF
Category: ETFs
Launch Date: 29-07-2022
AUM:
₹ 41.85 Cr
Expense Ratio
0.26%
Benchmark
BSE Healthcare TRI
ISIN
INF247L01BB1
Minimum Investment
500.0
Minimum Topup
0.0
Minimum SIP Amount
1000
Fund Manager
Mr. Swapnil Mayekar, Mr. Dishant Mehta, Mr. Rakesh Shetty
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 9.33 | 25.28 | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
47.5071
Last change
0.24 (0.5128%)
Fund Size (AUM)
₹ 41.85 Cr
Performance
20.45% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the S&P BSE Healthcare Total Return Index, subject to tracking error. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.
Fund Manager
Mr. Swapnil Mayekar, Mr. Dishant Mehta, Mr. Rakesh Shetty
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 13.91 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 5.9 |
| Dr. Reddys Laboratories Ltd | 5.74 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.55 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 5.28 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.23 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 3.97 |
| FORTIS HEALTHCARE LIMITED. EQ | 3.43 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 3.04 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 3.03 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.88 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.0 |